Viewing Study NCT07143318


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:07 AM
Study NCT ID: NCT07143318
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2025-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First-in-Human Single and Multiple Dose of KLA578-1 for Injection
Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-06-05
Start Date Type: ACTUAL
Primary Completion Date: 2026-05-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-05-31
Completion Date Type: ESTIMATED
First Submit Date: 2025-07-23
First Submit QC Date: None
Study First Post Date: 2025-08-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-19
Last Update Post Date: 2025-08-27
Last Update Post Date Type: ESTIMATED